Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis

Clinical trial NCT07682662 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07682662
Sponsor: University of Mississippi Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Vaso-Occlusive Pain Episode in Sickle Cell Disease Sickle Cell Disease (SCD)

Start date: 2026-08-01
Primary completion: 2029-08-31
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.